MedPath
HSA Approval

AXCEL MICONAZOLE CREAM 2% w/w

SIN10967P

AXCEL MICONAZOLE CREAM 2% w/w

AXCEL MICONAZOLE CREAM 2% w/w

June 3, 1999

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D01AC02

miconazole

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

MICONAZOLE NITRATE (MICRONISED)

2% w/w

Miconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL MICONAZOLE CREAM 2% w/w - HSA Approval | MedPath